_version_ 1828687167411453952
author Leysen, Seppe
Vanderkelen, Lise
Weeks, Stephen
Michiels, Chris
Strelkov, Sergei
author_facet Leysen, Seppe
Vanderkelen, Lise
Weeks, Stephen
Michiels, Chris
Strelkov, Sergei
author_sort Leysen, Seppe
collection KU Leuven: Lirias
container_issue 6
container_start_page 1113
container_title Cellular and Molecular Life Sciences
container_volume 70
description Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor of g-type lysozyme (PliG-Ec) in complex with Atlantic salmon g-type lysozyme (SalG) at a resolution of 0.95 Å, which is exceptionally high for a complex of two proteins. The structure reveals for the first time the mechanism of g-type lysozyme inhibition by the PliG family. The latter contains two specific conserved regions that are essential for its inhibitory activity. The inhibitory complex formation is based on a double 'key-lock' mechanism. The first key-lock element is formed by the insertion of two conserved PliG regions into the active site of the lysozyme. The second element is defined by a distinct pocket of PliG accommodating a lysozyme loop. Computational analysis indicates that this pocket represents a suitable site for small molecule binding, which opens an avenue for the development of novel antibacterial agents that suppress the inhibitory activity of PliG. sponsorship: Access to the synchrotron beamlines PROX-IMA1 at Soleil and X33 at the Deutsches Elektronen-Synchrotron is gratefully acknowledged, with a special 'thank you' to Dr. Andrew Thompson for help with ultrahigh-resolution data collection. We also thank Dr. Pavel Afonine for advice on crystallographic refinement. S. Leysen holds a doctoral grant from the K.U. Leuven. L. Vanderkelen holds a doctoral fellowship from the Flemish Institute for the Promotion of Scientific Technological Research (IWT). This work was further financially supported by a Research Grant (G.0363.08) from the Research Foundation-Flanders (F.W.O.-Vlaanderen) and from the KU Leuven Research Fund (research project METH/07/03). (K.U. Leuven, Flemish Institute for the Promotion of Scientific Technological Research (IWT), Research Foundation-Flanders ...
format Article in Journal/Newspaper
genre Atlantic salmon
Salmo salar
genre_facet Atlantic salmon
Salmo salar
id ftid14132:oai:lirias2repo.kuleuven.be:123456789/362011
institution Open Polar
language English
op_collection_id ftid14132
op_container_end_page 1122
op_doi https://doi.org/10.1007/s00018-012-1184-1
op_relation https://lirias.kuleuven.be/handle/123456789/362011
https://pubmed.ncbi.nlm.nih.gov/23086131
op_rights info:eu-repo/semantics/restrictedAccess
intranet
op_source ISSN:1420-682X
ISSN:1420-9071
Cellular and Molecular Life Sciences, vol. 70 (6), (1113-1122)
publishDate 2013
publisher Birkhäuser Verlag
record_format openpolar
spelling ftid14132:oai:lirias2repo.kuleuven.be:123456789/362011 2025-04-06T14:48:06+00:00 Structural basis of bacterial defense against g-type lysozyme-based innate immunity Leysen, Seppe Vanderkelen, Lise Weeks, Stephen Michiels, Chris Strelkov, Sergei 2013-03 https://lirias.kuleuven.be/handle/123456789/362011 https://doi.org/10.1007/s00018-012-1184-1 https://pubmed.ncbi.nlm.nih.gov/23086131 eng eng Birkhäuser Verlag https://lirias.kuleuven.be/handle/123456789/362011 https://pubmed.ncbi.nlm.nih.gov/23086131 info:eu-repo/semantics/restrictedAccess intranet ISSN:1420-682X ISSN:1420-9071 Cellular and Molecular Life Sciences, vol. 70 (6), (1113-1122) Science & Technology Life Sciences & Biomedicine Biochemistry & Molecular Biology Cell Biology Lysozyme inhibitor PliG Lysozyme Innate immunity Inhibitory complex Crystal structure GOOSE-TYPE LYSOZYMES ESCHERICHIA-COLI INHIBITOR SCATTERING CHITINASE PROTEINS COMPLEX SYSTEM HEALTH MODEL Animals Crystallography Escherichia coli Escherichia coli Proteins Immunity Innate Models Molecular Muramidase Protein Conformation Salmo salar 0601 Biochemistry and Cell Biology 0606 Physiology 1103 Clinical Sciences 3101 Biochemistry and cell biology 3205 Medical biochemistry and metabolomics 3211 Oncology and carcinogenesis Journal article info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion 2013 ftid14132 https://doi.org/10.1007/s00018-012-1184-1 2025-03-13T09:55:15Z Gram-negative bacteria can produce specific proteinaceous inhibitors to defend themselves against the lytic action of host lysozymes. So far, four different lysozyme inhibitor families have been identified. Here, we report the crystal structure of the Escherichia coli periplasmic lysozyme inhibitor of g-type lysozyme (PliG-Ec) in complex with Atlantic salmon g-type lysozyme (SalG) at a resolution of 0.95 Å, which is exceptionally high for a complex of two proteins. The structure reveals for the first time the mechanism of g-type lysozyme inhibition by the PliG family. The latter contains two specific conserved regions that are essential for its inhibitory activity. The inhibitory complex formation is based on a double 'key-lock' mechanism. The first key-lock element is formed by the insertion of two conserved PliG regions into the active site of the lysozyme. The second element is defined by a distinct pocket of PliG accommodating a lysozyme loop. Computational analysis indicates that this pocket represents a suitable site for small molecule binding, which opens an avenue for the development of novel antibacterial agents that suppress the inhibitory activity of PliG. sponsorship: Access to the synchrotron beamlines PROX-IMA1 at Soleil and X33 at the Deutsches Elektronen-Synchrotron is gratefully acknowledged, with a special 'thank you' to Dr. Andrew Thompson for help with ultrahigh-resolution data collection. We also thank Dr. Pavel Afonine for advice on crystallographic refinement. S. Leysen holds a doctoral grant from the K.U. Leuven. L. Vanderkelen holds a doctoral fellowship from the Flemish Institute for the Promotion of Scientific Technological Research (IWT). This work was further financially supported by a Research Grant (G.0363.08) from the Research Foundation-Flanders (F.W.O.-Vlaanderen) and from the KU Leuven Research Fund (research project METH/07/03). (K.U. Leuven, Flemish Institute for the Promotion of Scientific Technological Research (IWT), Research Foundation-Flanders ... Article in Journal/Newspaper Atlantic salmon Salmo salar KU Leuven: Lirias Cellular and Molecular Life Sciences 70 6 1113 1122
spellingShingle Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Cell Biology
Lysozyme inhibitor
PliG
Lysozyme
Innate immunity
Inhibitory complex
Crystal structure
GOOSE-TYPE LYSOZYMES
ESCHERICHIA-COLI
INHIBITOR
SCATTERING
CHITINASE
PROTEINS
COMPLEX
SYSTEM
HEALTH
MODEL
Animals
Crystallography
Escherichia coli
Escherichia coli Proteins
Immunity
Innate
Models
Molecular
Muramidase
Protein Conformation
Salmo salar
0601 Biochemistry and Cell Biology
0606 Physiology
1103 Clinical Sciences
3101 Biochemistry and cell biology
3205 Medical biochemistry and metabolomics
3211 Oncology and carcinogenesis
Leysen, Seppe
Vanderkelen, Lise
Weeks, Stephen
Michiels, Chris
Strelkov, Sergei
Structural basis of bacterial defense against g-type lysozyme-based innate immunity
title Structural basis of bacterial defense against g-type lysozyme-based innate immunity
title_full Structural basis of bacterial defense against g-type lysozyme-based innate immunity
title_fullStr Structural basis of bacterial defense against g-type lysozyme-based innate immunity
title_full_unstemmed Structural basis of bacterial defense against g-type lysozyme-based innate immunity
title_short Structural basis of bacterial defense against g-type lysozyme-based innate immunity
title_sort structural basis of bacterial defense against g-type lysozyme-based innate immunity
topic Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Cell Biology
Lysozyme inhibitor
PliG
Lysozyme
Innate immunity
Inhibitory complex
Crystal structure
GOOSE-TYPE LYSOZYMES
ESCHERICHIA-COLI
INHIBITOR
SCATTERING
CHITINASE
PROTEINS
COMPLEX
SYSTEM
HEALTH
MODEL
Animals
Crystallography
Escherichia coli
Escherichia coli Proteins
Immunity
Innate
Models
Molecular
Muramidase
Protein Conformation
Salmo salar
0601 Biochemistry and Cell Biology
0606 Physiology
1103 Clinical Sciences
3101 Biochemistry and cell biology
3205 Medical biochemistry and metabolomics
3211 Oncology and carcinogenesis
topic_facet Science & Technology
Life Sciences & Biomedicine
Biochemistry & Molecular Biology
Cell Biology
Lysozyme inhibitor
PliG
Lysozyme
Innate immunity
Inhibitory complex
Crystal structure
GOOSE-TYPE LYSOZYMES
ESCHERICHIA-COLI
INHIBITOR
SCATTERING
CHITINASE
PROTEINS
COMPLEX
SYSTEM
HEALTH
MODEL
Animals
Crystallography
Escherichia coli
Escherichia coli Proteins
Immunity
Innate
Models
Molecular
Muramidase
Protein Conformation
Salmo salar
0601 Biochemistry and Cell Biology
0606 Physiology
1103 Clinical Sciences
3101 Biochemistry and cell biology
3205 Medical biochemistry and metabolomics
3211 Oncology and carcinogenesis
url https://lirias.kuleuven.be/handle/123456789/362011
https://doi.org/10.1007/s00018-012-1184-1
https://pubmed.ncbi.nlm.nih.gov/23086131